• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 ALIGN URETHRAL SUPPORT SYSTEM RETROPUBIC; ALIGN® URETHRAL SUPPORT SYSTEM RETROPUBIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 ALIGN URETHRAL SUPPORT SYSTEM RETROPUBIC; ALIGN® URETHRAL SUPPORT SYSTEM RETROPUBIC Back to Search Results
Model Number BRD100R
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Therapeutic or Diagnostic Output Failure (3023)
Patient Problems Micturition Urgency (1871); Urinary Frequency (2275); Injury (2348)
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.No sample received.
 
Event Description
The patient's attorney alleged a deficiency against the device.Per additional information received, the patient has experienced frequent urination, pressure, urinary urgency, and frequency.The patient required non-surgical interventions.
 
Manufacturer Narrative
The sample was not returned.The finished product met all specifications prior to being released for general distribution.The instructions for use which accompanies all devices currently addresses potential risks associated with surgically implanted materials.The instructions for use states in the adverse events: "complications associated with the proper implantation of the align¿ urethral support system may include, but are not limited to: postoperative hematoma, which may occur following the implant procedure temporary urinary retention, bladder outlet obstruction, and voiding difficulties associated with over-correction / too much tension placed on the mesh sling implant perforations or lacerations of vessels, nerves, bladder or any viscera, which may occur during introducer needle passage.Transitory irritation at the operative wound site, which may elicit a foreign body response that leads to inflammation, infection, or erosion of the implant." 2348, 2275, 1871, 2993, = "nl".H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALIGN URETHRAL SUPPORT SYSTEM RETROPUBIC
Type of Device
ALIGN® URETHRAL SUPPORT SYSTEM RETROPUBIC
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
MDR Report Key11077601
MDR Text Key223782271
Report Number1018233-2020-06412
Device Sequence Number1
Product Code OTN
UDI-Device Identifier00801741016172
UDI-Public(01)00801741016172
Combination Product (y/n)N
PMA/PMN Number
K093747
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup
Report Date 01/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/30/2014
Device Model NumberBRD100R
Device Catalogue NumberBRD100R
Device Lot NumberHUWG1782
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Device Age8 MO
Event Location Hospital
Initial Date Manufacturer Received 12/07/2020
Initial Date FDA Received12/28/2020
Supplement Dates Manufacturer Received01/11/2021
Supplement Dates FDA Received01/13/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
PELVISOFT® ACELLULAR COLLAGEN BIOMESH.; PELVISOFT® ACELLULAR COLLAGEN BIOMESH
Patient Outcome(s) Required Intervention;
Patient Age43 YR
Patient Weight102
-
-